Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Change in Inventory (2018 - 2025)

Historic Change in Inventory for Agios Pharmaceuticals (AGIO) over the last 7 years, with Q4 2025 value amounting to $886000.0.

  • Agios Pharmaceuticals' Change in Inventory fell 2535.8% to $886000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $5.3 million, marking a year-over-year decrease of 3789.23%. This contributed to the annual value of $5.3 million for FY2025, which is 3789.23% down from last year.
  • Agios Pharmaceuticals' Change in Inventory amounted to $886000.0 in Q4 2025, which was down 2535.8% from $1.2 million recorded in Q3 2025.
  • In the past 5 years, Agios Pharmaceuticals' Change in Inventory registered a high of $4.3 million during Q2 2023, and its lowest value of $867000.0 during Q2 2024.
  • In the last 4 years, Agios Pharmaceuticals' Change in Inventory had a median value of $1.7 million in 2023 and averaged $2.1 million.
  • In the last 5 years, Agios Pharmaceuticals' Change in Inventory skyrocketed by 17282.54% in 2023 and then tumbled by 7982.31% in 2024.
  • Over the past 4 years, Agios Pharmaceuticals' Change in Inventory (Quarter) stood at $3.3 million in 2022, then crashed by 45.66% to $1.8 million in 2023, then crashed by 34.13% to $1.2 million in 2024, then fell by 25.36% to $886000.0 in 2025.
  • Its Change in Inventory stands at $886000.0 for Q4 2025, versus $1.2 million for Q3 2025 and $1.2 million for Q2 2025.